UniProt ID | ZC3HF_HUMAN | |
---|---|---|
UniProt AC | Q8WU90 | |
Protein Name | Zinc finger CCCH domain-containing protein 15 | |
Gene Name | ZC3H15 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 426 | |
Subcellular Localization | Cytoplasm . Nucleus. The DRG1-DFRP2/ZC3H15 complex associates with polysomes. | |
Protein Description | Protects DRG1 from proteolytic degradation.. | |
Protein Sequence | MPPKKQAQAGGSKKAEQKKKEKIIEDKTFGLKNKKGAKQQKFIKAVTHQVKFGQQNPRQVAQSEAEKKLKKDDKKKELQELNELFKPVVAAQKISKGADPKSVVCAFFKQGQCTKGDKCKFSHDLTLERKCEKRSVYIDARDEELEKDTMDNWDEKKLEEVVNKKHGEAEKKKPKTQIVCKHFLEAIENNKYGWFWVCPGGGDICMYRHALPPGFVLKKDKKKEEKEDEISLEDLIERERSALGPNVTKITLESFLAWKKRKRQEKIDKLEQDMERRKADFKAGKALVISGREVFEFRPELVNDDDEEADDTRYTQGTGGDEVDDSVSVNDIDLSLYIPRDVDETGITVASLERFSTYTSDKDENKLSEASGGRAENGERSDLEEDNEREGTENGAIDAVPVDENLFTGEDLDELEEELNTLDLEE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
12 | Phosphorylation | KQAQAGGSKKAEQKK HHHCCCCCHHHHHHH | 30.02 | 21601212 | |
22 | Ubiquitination | AEQKKKEKIIEDKTF HHHHHHHHHHHCCCC | 58.84 | 23000965 | |
27 | Ubiquitination | KEKIIEDKTFGLKNK HHHHHHCCCCCCCCC | 32.72 | 23000965 | |
27 | 2-Hydroxyisobutyrylation | KEKIIEDKTFGLKNK HHHHHHCCCCCCCCC | 32.72 | - | |
27 | Acetylation | KEKIIEDKTFGLKNK HHHHHHCCCCCCCCC | 32.72 | 91341 | |
28 | Phosphorylation | EKIIEDKTFGLKNKK HHHHHCCCCCCCCCC | 34.95 | 18212344 | |
32 | Ubiquitination | EDKTFGLKNKKGAKQ HCCCCCCCCCCCHHH | 68.08 | 23000965 | |
35 | Acetylation | TFGLKNKKGAKQQKF CCCCCCCCCHHHHHH | 73.77 | 7495747 | |
38 | Acetylation | LKNKKGAKQQKFIKA CCCCCCHHHHHHHHH | 63.03 | 7495757 | |
38 | Ubiquitination | LKNKKGAKQQKFIKA CCCCCCHHHHHHHHH | 63.03 | 23000965 | |
41 | Ubiquitination | KKGAKQQKFIKAVTH CCCHHHHHHHHHHHH | 46.71 | 23000965 | |
44 | Acetylation | AKQQKFIKAVTHQVK HHHHHHHHHHHHHHH | 39.68 | 7495767 | |
44 | Ubiquitination | AKQQKFIKAVTHQVK HHHHHHHHHHHHHHH | 39.68 | 23000965 | |
51 | Ubiquitination | KAVTHQVKFGQQNPR HHHHHHHHCCCCCHH | 36.89 | 23000965 | |
51 | Acetylation | KAVTHQVKFGQQNPR HHHHHHHHCCCCCHH | 36.89 | 26051181 | |
54 | Ubiquitination | THQVKFGQQNPRQVA HHHHHCCCCCHHHHH | 42.90 | - | |
61 | Ubiquitination | QQNPRQVAQSEAEKK CCCHHHHHHHHHHHH | 9.99 | 24816145 | |
63 | Phosphorylation | NPRQVAQSEAEKKLK CHHHHHHHHHHHHHC | 29.09 | 26546556 | |
64 | Acetylation | PRQVAQSEAEKKLKK HHHHHHHHHHHHHCH | 49.09 | - | |
64 | Ubiquitination | PRQVAQSEAEKKLKK HHHHHHHHHHHHHCH | 49.09 | 24816145 | |
67 | Acetylation | VAQSEAEKKLKKDDK HHHHHHHHHHCHHHH | 71.15 | 25953088 | |
76 | Ubiquitination | LKKDDKKKELQELNE HCHHHHHHHHHHHHH | 70.20 | - | |
80 | Ubiquitination | DKKKELQELNELFKP HHHHHHHHHHHHHHH | 67.21 | - | |
80 | Ubiquitination | DKKKELQELNELFKP HHHHHHHHHHHHHHH | 67.21 | 22053931 | |
86 | Acetylation | QELNELFKPVVAAQK HHHHHHHHHHHHHHH | 49.91 | 23954790 | |
86 | Ubiquitination | QELNELFKPVVAAQK HHHHHHHHHHHHHHH | 49.91 | 29967540 | |
93 | Acetylation | KPVVAAQKISKGADP HHHHHHHHHHCCCCC | 44.19 | 25953088 | |
93 | Ubiquitination | KPVVAAQKISKGADP HHHHHHHHHHCCCCC | 44.19 | 33845483 | |
95 | Phosphorylation | VVAAQKISKGADPKS HHHHHHHHCCCCCCC | 31.88 | - | |
109 | Acetylation | SVVCAFFKQGQCTKG CEEEEEEECCCCCCC | 47.25 | 25953088 | |
135 | Phosphorylation | ERKCEKRSVYIDARD CCHHHCCCEEEECCC | 30.27 | 26552605 | |
137 | Phosphorylation | KCEKRSVYIDARDEE HHHCCCEEEECCCHH | 8.37 | 28796482 | |
147 | Ubiquitination | ARDEELEKDTMDNWD CCCHHHHHHCCCCCC | 71.74 | 29967540 | |
147 | Acetylation | ARDEELEKDTMDNWD CCCHHHHHHCCCCCC | 71.74 | 26051181 | |
149 | Phosphorylation | DEELEKDTMDNWDEK CHHHHHHCCCCCCHH | 37.18 | - | |
157 | Ubiquitination | MDNWDEKKLEEVVNK CCCCCHHHHHHHHHH | 60.11 | 22053931 | |
161 | Ubiquitination | DEKKLEEVVNKKHGE CHHHHHHHHHHHCCH | 4.14 | 22817900 | |
164 | 2-Hydroxyisobutyrylation | KLEEVVNKKHGEAEK HHHHHHHHHCCHHHH | 34.24 | - | |
181 | Acetylation | PKTQIVCKHFLEAIE CCHHHHHHHHHHHHH | 26.88 | 26051181 | |
218 | Acetylation | LPPGFVLKKDKKKEE CCCCEEEECCCCCHH | 54.33 | 26051181 | |
226 | Ubiquitination | KDKKKEEKEDEISLE CCCCCHHCCCCCCHH | 72.12 | 29967540 | |
231 | Phosphorylation | EEKEDEISLEDLIER HHCCCCCCHHHHHHH | 24.53 | 29255136 | |
241 | Phosphorylation | DLIERERSALGPNVT HHHHHHHHCCCCCCE | 24.08 | 28258704 | |
259 | Acetylation | LESFLAWKKRKRQEK HHHHHHHHHHHHHHH | 36.77 | 24431543 | |
259 | Ubiquitination | LESFLAWKKRKRQEK HHHHHHHHHHHHHHH | 36.77 | - | |
260 | Ubiquitination | ESFLAWKKRKRQEKI HHHHHHHHHHHHHHH | 53.07 | - | |
266 | Ubiquitination | KKRKRQEKIDKLEQD HHHHHHHHHHHHHHH | 48.11 | 24816145 | |
269 | Ubiquitination | KRQEKIDKLEQDMER HHHHHHHHHHHHHHH | 58.35 | 24816145 | |
269 | Acetylation | KRQEKIDKLEQDMER HHHHHHHHHHHHHHH | 58.35 | 23236377 | |
274 | Sulfoxidation | IDKLEQDMERRKADF HHHHHHHHHHHHHHH | 4.28 | 21406390 | |
285 | Acetylation | KADFKAGKALVISGR HHHHHCCCEEEECCC | 43.33 | 25953088 | |
285 | Ubiquitination | KADFKAGKALVISGR HHHHHCCCEEEECCC | 43.33 | 21890473 | |
314 | Phosphorylation | EEADDTRYTQGTGGD CCCCCCCCCCCCCCC | 12.90 | 20873877 | |
315 | Phosphorylation | EADDTRYTQGTGGDE CCCCCCCCCCCCCCC | 19.75 | 20873877 | |
318 | Phosphorylation | DTRYTQGTGGDEVDD CCCCCCCCCCCCCCC | 28.33 | 20873877 | |
326 | Phosphorylation | GGDEVDDSVSVNDID CCCCCCCCCEECCEE | 16.30 | 20873877 | |
328 | Phosphorylation | DEVDDSVSVNDIDLS CCCCCCCEECCEEEE | 21.10 | 28348404 | |
335 | Phosphorylation | SVNDIDLSLYIPRDV EECCEEEEEECCCCC | 18.51 | 29978859 | |
337 | Phosphorylation | NDIDLSLYIPRDVDE CCEEEEEECCCCCCC | 12.90 | 27080861 | |
345 | Phosphorylation | IPRDVDETGITVASL CCCCCCCCCCEEEEE | 29.44 | 23663014 | |
348 | Phosphorylation | DVDETGITVASLERF CCCCCCCEEEEEEEE | 16.03 | 23663014 | |
351 | Phosphorylation | ETGITVASLERFSTY CCCCEEEEEEEEECC | 26.82 | 30266825 | |
356 | Phosphorylation | VASLERFSTYTSDKD EEEEEEEECCCCCCC | 27.07 | 23927012 | |
357 | Phosphorylation | ASLERFSTYTSDKDE EEEEEEECCCCCCCC | 28.27 | 23927012 | |
358 | Phosphorylation | SLERFSTYTSDKDEN EEEEEECCCCCCCCC | 11.75 | 23927012 | |
359 | Phosphorylation | LERFSTYTSDKDENK EEEEECCCCCCCCCC | 30.45 | 23927012 | |
360 | Phosphorylation | ERFSTYTSDKDENKL EEEECCCCCCCCCCH | 32.05 | 23401153 | |
362 | Ubiquitination | FSTYTSDKDENKLSE EECCCCCCCCCCHHH | 67.71 | 21906983 | |
362 | 2-Hydroxyisobutyrylation | FSTYTSDKDENKLSE EECCCCCCCCCCHHH | 67.71 | - | |
362 | Acetylation | FSTYTSDKDENKLSE EECCCCCCCCCCHHH | 67.71 | 23749302 | |
366 | Ubiquitination | TSDKDENKLSEASGG CCCCCCCCHHHHCCC | 51.87 | 33845483 | |
366 | Acetylation | TSDKDENKLSEASGG CCCCCCCCHHHHCCC | 51.87 | 26051181 | |
368 | Phosphorylation | DKDENKLSEASGGRA CCCCCCHHHHCCCCC | 32.50 | 23927012 | |
371 | Phosphorylation | ENKLSEASGGRAENG CCCHHHHCCCCCCCC | 37.42 | 25159151 | |
381 | Phosphorylation | RAENGERSDLEEDNE CCCCCCCCCCCCCCC | 42.09 | 29255136 | |
392 | Phosphorylation | EDNEREGTENGAIDA CCCCCCCCCCCCCCE | 22.86 | 26074081 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZC3HF_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZC3HF_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZC3HF_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
DRG1_HUMAN | DRG1 | physical | 15676025 | |
ZCHC8_HUMAN | ZCCHC8 | physical | 22939629 | |
TRAF2_HUMAN | TRAF2 | physical | 23624947 | |
ABCF2_HUMAN | ABCF2 | physical | 26344197 | |
DRG1_HUMAN | DRG1 | physical | 26344197 | |
FAF1_HUMAN | FAF1 | physical | 26344197 | |
PSF3_HUMAN | GINS3 | physical | 26344197 | |
HMGN5_HUMAN | HMGN5 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-351, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-381, AND MASSSPECTROMETRY. |